Luis A Topete, MD, Luz S Romero, MD, Rodrigo Aceves, MD, Ayermin Vargas, MD, Martin E Rojano, Roberto Delano, MD, José De Jesus Herrera, MD. Hospital General “Dr. Manuel Gea González”
Introduction: In 1985, Garren-Edwards introduce the intragastric balloon. It was removed from market after several complications such as deflation and migration of the balloon. Outcomes in the usage of intragastric balloon published in other countries show a percentage of excess weight loss of 60%, and a weight regain of 35% after retrieval of balloon. Intragastric balloon therapy has been use as first option therapy for patient with obesity type I and also as bridge therapy in patients with morbid obesity, Nonetheless, there are none clinical trials publish in Mexico of the outcomes of usage of intragastric balloon.
Objective: Main purpose of the study is to report the percentage of excess weight loss and weight regain after retrieval of intragastric balloon in the General Hospital “Dr. Manuel Gea González” in the last 5 years.
Material and methods: We conducted a research from database at the Clinic of Obesity of the General Hospital “Dr. Manuel Gea González” in search of patients who underwent an endoscopic intragastric balloon placement as therapy of weight loss from January 2012 to November 2017. We analyze demographics characteristics of patients, weight before intragastric balloon therapy, type of intragastric balloon, time of intragastric balloon therapy, symptoms after intragastric balloon placement. Follow up of patient with weight was recorded at 1, 3, 6, 9, 12 and 18 months. Additionally, it was specifying if the patient underwent a bariatric surgery after retrieval of intragastric balloon.
Outcomes: From January 2012 to November 2017, we found 22 patients who underwent intragastric balloon therapy. The average age of patient was 41.6 years, average Body Mass Index was 41.4 kg/m2, 6 patients were male and 16 were women. Percentage of excess weight loss was 34.9% with a weight regain after retrieval of intragastric balloon at 1 year of follow up. We had the same outcomes in terms of percentage of excess weight loss with the two different types of intragastric balloon. We included patients undergoing interval therapy and also as first option therapy. Five patients underwent bariatric surgery after balloon retrieval reaching a percentage of excess weight loss of 45.6% six months after removal. In terms of symptoms, none of the patients underwent early removal of the balloon and only 7 patients suffer from mild symptoms after placement of the balloon.
Conclusions: Our study shows similar outcomes as previous reports regarding weight regain and percentage of excess weight loss.
Presented at the SAGES 2017 Annual Meeting in Houston, TX.
Abstract ID: 95184
Program Number: P172
Presentation Session: Poster Session (Non CME)
Presentation Type: Poster